@hottuna says the results are rubbish
@The Yankee says they are sensational
@Southoz reckons they look OK, but she/he needs more information to be sure
But the only people whose opinions really matter are MSB's prospective partners, not one of which - other than the now-disengaged Teva - has committed any capital to MSB's various programs for a period going on for seven years.
With the cash balance heading to ~$35m in 6 weeks' time, and probably to under $20m three months later (which would be the lowest level of cash MSB has held in the past 29 quarters), something has clearly got to happen in the next 90-odd business days.
Or else the equity finance facility will need to be activated.
Ann: Positive Nine Month RA Results For Mesoblast Cell Therapy, page-27
-
- There are more pages in this discussion • 18 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.46 |
Change
0.065(4.66%) |
Mkt cap ! $1.684B | |||
| Open | High | Low | Value | Volume |
| $1.41 | $1.50 | $1.40 | $5.191M | 3.595M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 30 | 22398 | $1.46 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.46 | 46753 | 9 |
View Market Depth
| Last trade - 15.44pm 11/11/2024 (20 minute delay) ? |
| MSB (ASX) Chart |